Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Singleton infants born at 25-32 weeks gestation who are \< 38 weeks post-conceptual age at enrollment~2. First infant of twin gestation born at 25-32 weeks gestation who requires a blood transfusion; if both infants require transfusion on the same day the larger infant will be enrolled.~3. Receiving bolus enteral feeds \[PO (bottle) and/or PE (feeding tube)\] of at least 60 cc/kg/day~4. A planned packed red blood cell transfusion, as per the clinical team, for anemia~5. Infant is very likely to require a blood transfusion according to the attending neonatologist.~Exclusion Criteria:~1. Known congenital anomalies of the heart, brain, kidneys or intestine~2. Chromosomal abnormality~3. Intrauterine growth restriction at \< 3% for weight at birth since this has been shown to alter mesenteric BFV and the post-prandial hyperemia~4. Twin to twin transfusion sequence~5. Higher order multiples~6. Patent ductus arteriosus known to be present or currently being treated~7. History of definite necrotizing enterocolitis Bell Stage 2 or greater~8. Concurrent treatments with antibiotics or steroids~9. Feeding intolerance, defined as gastric aspirate \> 30% of feed volume on 3 sequential feeds~10. Concurrent enrollment in another randomized trial~11. Infants discharged or transferred to another facility without having received a PRBC transfusion will be excluded post-hoc.

- Gender: ALL
- Minimum Age: 25 Weeks
- Maximum Age: 38 Weeks
- Healthy Volunteers: f

Study Arms:
- group 1 (Type: NO_INTERVENTION): All babies \<1250 gm at the time of the study are enrolled into this arm, and randomized to be NPO during the PRBC transfusion
- group 2 (Type: ACTIVE_COMPARATOR): Babies \<1250 gm at the time of the study are enrolled into this arm, and randomized to be fed during the PRBC transfusion
- group 3 (Type: NO_INTERVENTION): All babies \>1250 gm at the time of the study are enrolled into this arm, and randomized to be fed during the PRBC transfusion
- group 4 (Type: EXPERIMENTAL): All babies \<1250 gm at the time of the study are enrolled into this arm, and randomized to be fed during the PRBC transfusion

Based on this trial design, predict the completion outcome and termination type (if applicable).